Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Patients With Brain Metastasis

NCT00681551 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Brain Neoplasms

Interventions

DRUG: Magnevist (SH L 451A)
DRUG: Magnevist (SH L 451A)

Sponsor

Bayer